Boxer Capital as of Dec. 31, 2021
Portfolio Holdings for Boxer Capital
Boxer Capital holds 71 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 11.4 | $293M | 2.0M | 146.69 | |
Spdr Ser Tr S&p Biotech (XBI) | 9.6 | $246M | 2.2M | 111.96 | |
Iteos Therapeutics (ITOS) | 7.9 | $202M | 4.3M | 46.56 | |
BeiGene Sponsored Adr (BGNE) | 5.3 | $136M | 500k | 270.93 | |
Springworks Therapeutics (SWTX) | 5.0 | $129M | 2.1M | 61.98 | |
Cytokinetics Com New (CYTK) | 3.7 | $96M | 2.1M | 45.58 | |
Tyra Biosciences (TYRA) | 3.5 | $91M | 6.4M | 14.07 | |
Revolution Medicines (RVMD) | 3.4 | $88M | 3.5M | 25.17 | |
Relay Therapeutics (RLAY) | 3.2 | $82M | 2.7M | 30.71 | |
Tango Therapeutics (TNGX) | 2.9 | $75M | 6.9M | 10.94 | |
Pmv Pharmaceuticals (PMVP) | 2.5 | $66M | 2.8M | 23.10 | |
Spdr Ser Tr Call Call Option | 2.4 | $62M | 550k | 111.96 | |
Merus N V (MRUS) | 2.3 | $60M | 1.9M | 31.80 | |
Arcus Biosciences Incorporated (RCUS) | 2.3 | $58M | 1.4M | 40.47 | |
Blueprint Medicines (BPMC) | 2.1 | $54M | 507k | 107.11 | |
Ideaya Biosciences (IDYA) | 2.0 | $52M | 2.2M | 23.64 | |
Sage Therapeutics (SAGE) | 1.8 | $47M | 1.1M | 42.54 | |
Anaptysbio Inc Common (ANAB) | 1.8 | $45M | 1.3M | 34.75 | |
Nuvation Bio Com Cl A (NUVB) | 1.4 | $37M | 4.3M | 8.50 | |
Nurix Therapeutics (NRIX) | 1.4 | $36M | 1.2M | 28.95 | |
Kinnate Biopharma | 1.3 | $33M | 1.8M | 17.72 | |
Rocket Pharmaceuticals (RCKT) | 1.2 | $32M | 1.5M | 21.83 | |
Fate Therapeutics (FATE) | 1.1 | $29M | 500k | 58.51 | |
Gossamer Bio (GOSS) | 1.1 | $28M | 2.5M | 11.31 | |
Amicus Therapeutics (FOLD) | 1.0 | $27M | 2.3M | 11.55 | |
Avidity Biosciences Ord (RNA) | 1.0 | $27M | 1.1M | 23.77 | |
Bellus Health Com New | 1.0 | $26M | 3.2M | 8.05 | |
GH Research Ordinary Shares (GHRS) | 0.9 | $24M | 1.0M | 23.33 | |
Nuvalent Inc-a (NUVL) | 0.9 | $23M | 1.2M | 19.04 | |
Iovance Biotherapeutics (IOVA) | 0.8 | $21M | 1.1M | 19.09 | |
Day One Biopharmaceuticals I (DAWN) | 0.8 | $20M | 1.2M | 16.85 | |
Xenon Pharmaceuticals (XENE) | 0.7 | $19M | 600k | 31.24 | |
Aligos Therapeutics (ALGS) | 0.7 | $18M | 1.5M | 11.87 | |
Akero Therapeutics (AKRO) | 0.7 | $18M | 832k | 21.15 | |
Ultragenyx Pharmaceutical (RARE) | 0.7 | $17M | 200k | 84.09 | |
Cullinan Oncology (CGEM) | 0.6 | $17M | 1.1M | 15.43 | |
Rain Therapeutics | 0.6 | $15M | 1.2M | 12.88 | |
Prothena Corporation SHS (PRTA) | 0.6 | $15M | 300k | 49.40 | |
Milestone Pharmaceuticals (MIST) | 0.6 | $15M | 2.2M | 6.55 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $14M | 1.3M | 11.26 | |
Point Biopharma Global | 0.5 | $14M | 2.5M | 5.60 | |
Bioatla (BCAB) | 0.5 | $14M | 686k | 19.63 | |
Theseus Pharmaceuticals | 0.4 | $11M | 892k | 12.68 | |
Black Diamond Therapeutics (BDTX) | 0.4 | $11M | 2.0M | 5.33 | |
Selecta Biosciences | 0.4 | $11M | 3.3M | 3.26 | |
Essa Pharma Com New (EPIX) | 0.4 | $10M | 725k | 14.20 | |
Codiak Biosciences | 0.4 | $9.5M | 850k | 11.14 | |
Ngm Biopharmaceuticals | 0.3 | $8.9M | 500k | 17.71 | |
Biomea Fusion (BMEA) | 0.3 | $8.9M | 1.2M | 7.45 | |
MEI Pharma Com New | 0.3 | $7.8M | 2.9M | 2.67 | |
Eqrx | 0.3 | $6.8M | 1.0M | 6.82 | |
Atreca Cl A Com (BCEL) | 0.3 | $6.7M | 2.2M | 3.03 | |
Odonate Therapeutics Ord | 0.2 | $5.7M | 4.2M | 1.35 | |
Solid Biosciences | 0.2 | $5.6M | 3.2M | 1.75 | |
Elevation Oncology (ELEV) | 0.2 | $5.3M | 873k | 6.02 | |
BCLS Acquisition Corp Com Cl A | 0.2 | $4.9M | 500k | 9.80 | |
JIYA Acquisition Corp Com Cl A | 0.2 | $4.9M | 500k | 9.77 | |
Research Alliance Corp II Com Cl A | 0.2 | $4.9M | 500k | 9.77 | |
Panacea Acquisition Corp II Cl A Shs | 0.2 | $4.9M | 500k | 9.70 | |
ACADIA Pharmaceuticals (ACAD) | 0.2 | $4.3M | 185k | 23.34 | |
Health Sciences Acquisition Corp II Ord Shs | 0.2 | $4.0M | 400k | 10.08 | |
Helix Acquisition Corp Com Cl A | 0.2 | $4.0M | 400k | 9.89 | |
Gemini Therapeutics | 0.1 | $3.8M | 1.3M | 2.91 | |
DBV Technologies SA Sponsored Adr | 0.1 | $3.4M | 2.1M | 1.60 | |
Oric Pharmaceuticals (ORIC) | 0.1 | $2.9M | 200k | 14.70 | |
Cabaletta Bio (CABA) | 0.1 | $2.0M | 540k | 3.79 | |
Omega Alpha SPAC Cl A | 0.1 | $2.0M | 200k | 9.77 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $1.4M | 209k | 6.75 | |
Genocea Biosciences Com New (GNCAQ) | 0.1 | $1.3M | 1.1M | 1.16 | |
Surrozen | 0.1 | $1.3M | 200k | 6.44 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $504k | 267k | 1.89 |